I haven’t heard any discussion about the possibility of ramping up production — at least for the international market — using approval from a foreign drug agency (like Japan or Korea). In a worst-case scenario, such approval would (presumably) open up those markets. And the product may even be allowed into the US on an emergency use basis. This doesn’t strike me as particularly far-fetched. Could it be viable way forward?